Protagonist Therapeutics
About:
Protagonist Therapeutics develops orally-stable peptides to treat diseases that are currently addressed by injectable antibodies.
Website: http://www.protagonist-inc.com
Twitter/X: ProtagonistTx
Top Investors: RA Capital Management, MidCap Financial, National Institutes of Health, Foresite Capital, Silicon Valley Bank
Description:
Protagonist Therapeutics is a biotechnology company dedicated to the discovery of novel peptide and small molecule compounds that mimic or inhibit therapeutically-relevant protein-protein interactions.
$389M
$50M to $100M
Brisbane, Queensland, Australia
2001-01-01
info(AT)protagonist-inc.com
Mark Smythe
51-100
2021-06-14
Public
© 2025 bioDAO.ai